PrEP through pharmacies for young women in Tanzania
Part of Infections clinical trials.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 24 years old.
- You live in one of five study areas in the Shinyanga, Geita, or Kagera regions of Tanzania and plan to stay there.
- You want to start PrEP to protect yourself from HIV.
- You can use a mobile phone (your own or someone else's).
- You are not already taking PrEP (have not refilled a PrEP prescription in the last 28 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study tests whether pharmacies can safely provide HIV prevention medications (PrEP for prevention, PEP for emergency treatment) and HIV testing through phone or video visits. It aims to make these services easier to access without visiting a hospital or clinic.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study tests a new computer tool designed to help young adults and healthcare providers make better decisions about PrEP (a daily pill that prevents HIV). Researchers want to understand how this tool works in real clinics in Alabama and Botswana.
This study tests a program to help young women and girls stick with their HIV prevention medication (PrEP). It explores whether extra support can make it easier to stay on PrEP and protect against HIV.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.